https://european-biotechnology.net/wp-content/uploads/2024/12/Sorbonne.jpg
401
700
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-12-16 08:29:152024-12-16 08:29:15Membrane target triggers inflammation
https://european-biotechnology.net/wp-content/uploads/2024/12/EB424_FlorisvanDelft_SYNAFFIX_tg-e1734020314506.jpg
532
945
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-12-12 16:19:102024-12-12 16:19:10Elevation Oncology Inc licences Synaffix BV’s ADC platform
https://european-biotechnology.net/wp-content/uploads/2024/12/ProQR-TherapeuticsRSRTjpg-1030x449-1.png
449
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-12-12 08:59:012024-12-12 08:59:01RNA specialist ProQR Therapeutics NV bags US$8.1m funding
https://european-biotechnology.net/wp-content/uploads/2024/12/DSC5297_StandardJPEG100_crop-1030x562-1.jpg
562
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-12-11 08:41:452024-12-12 10:02:07Breakthroughs honoured: 2024 Nobel Prizes
https://european-biotechnology.net/wp-content/uploads/2024/12/Noema-e1733906107756-1030x579-1.png
579
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-12-11 08:36:072024-12-12 10:02:07Noema Pharma AG extends Series B financing
https://european-biotechnology.net/wp-content/uploads/2024/12/Cyrill_©-Volker-Brinkmann-MPI-for-Infection-Biology-Berlin-1030x603-1.png
603
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-12-09 09:13:552024-12-12 10:02:07Citryll BV raises €85m in Series B financing
https://european-biotechnology.net/wp-content/uploads/2024/12/Dewpoint-e1733404904642-1030x579-1.png
579
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-12-06 08:02:582024-12-12 10:02:07Dewpoint Therapeutics and Mitsubishi Tanabe partner on ALS therapy
https://european-biotechnology.net/wp-content/uploads/2024/12/Eli_Lilly_vials-e1733390268973.jpg
225
400
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-12-05 09:18:342024-12-12 10:02:07UK first country in Europe to reimburse tirzepatide
https://european-biotechnology.net/wp-content/uploads/2024/12/Ipsen_MAITs-1030x502-1.png
502
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-12-04 09:48:182024-12-12 10:02:07French Ipsen inks US$610m biobucks deal with Biomunex SA
https://european-biotechnology.net/wp-content/uploads/2024/12/Resalis-Preclinical.png
482
922
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-12-04 07:07:112024-12-12 10:02:07Obesity gene therapy enters Phase I testing
Scroll to top
